- Home
- Smeeta Sinha
Smeeta Sinha
Northern Care Alliance NHS Foundation Trust, Manchester, UK
Biography
Prof Smeeta Sinha is Consultant Nephrologist at the Northern Care Alliance NHS Foundation Trust and Honorary Professor at the University of Manchester, UK. She served as Clinical Director for Renal Services from 2014 to 2020, expanding kidney care across Greater Manchester. In 2021, she became Deputy Director for Research & Innovation at Northern Care Alliance.
Her clinical interests include CKD, metabolic stone disease and glomerulonephritis. She leads the integrated glomerulonephritis service at Salford Royal, covering 1.3 million people.
Her research focuses on CKD-mineral bone disorder, vascular calcification, glomerulonephritis and rare renal diseases. She is an internationally recognised expert in calciphylaxis and supports trials from Phase 1 to 3.
Featured Courses
- 1.00
Published:
Learning objectives
- Define residual inflammatory risk (RIR) and explain why cardiovascular events continue to occur in patients despite optimal lipid-lowering and antihypertensive therapies
- Describe the pathophysiological role of inflammation in atherosclerosis, myocardial infarction, heart failure and chronic kidney disease
- Identify patients at increased cardiovascular risk due to elevated inflammatory markers, particularly high-sensitivity C-reactive protein (hsCRP)
- Interpret the clinical significance of hsCRP and other inflammatory biomarkers in primary and secondary prevention settings, in alignment with current evidence and guideline recommendations
- Assess clinician practices, barriers and strategies for integrating inflammatory risk assessment and management
- Apply key takeaways to inform future risk assessment and treatment decisions in patients with or at risk for cardiovascular disease